23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...

On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

(Yicai) Nov. 15 -- The Germany’ Merck and five other overseas pharmaceutical companies have been given the green light to ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Me, a pioneer in genetic testing, struggles to maintain its early success. As quickly as it soared, its market value ...

The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

In this photo illustration, a 23andMe logo seen displayed on a smartphone and in the background. The company announced Monday ...

The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...